Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
about
Phagocytosis of microglia in the central nervous system diseasesCorrelations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis.Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegenerationPossible association between dysfunction of vitamin D binding protein (GC Globulin) and migraine attacksDiscrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion diseasePrenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cellsPreliminary expression profile of cytokines in brain tissue of BALB/c mice with Angiostrongylus cantonensis infectionNovel Role of TRPML2 in the Regulation of the Innate Immune ResponseP2Y6 Receptor-Mediated Microglial Phagocytosis in Radiation-Induced Brain Injury.CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner.CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues.Cytokine-like 1 Chemoattracts Monocytes/Macrophages via CCR2.CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis.The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.Applications of chemokines as adjuvants for vaccine immunotherapy.Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?Distinguishing features of microglia- and monocyte-derived macrophages after stroke.The positive correlation of the CCL2-CCR2 axis with the disease activity may indicate the fundamental role in the pathogenesis of oral lichen planus.MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model.Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6.Innate Immune Signaling and Alcohol Use Disorders.Forensic Potential of MMPs and CC Chemokines for Wound Age Determination.APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats.Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension.Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cellsBidirectional Microglia-Neuron Communication in Health and DiseaseAstrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusionEffect of chemokine CC ligand 2 (CCL2) on α‑synuclein‑induced microglia proliferation and neuronal apoptosisDifferential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model
P2860
Q33574527-11E38F91-65EF-4989-834D-0E750A6C4FE6Q33980736-05C9DD31-922F-4430-9458-5F35619C46C1Q34050769-AA274F2C-5498-48B3-B088-DB3680027121Q34078607-AD056E0D-53C1-4F66-B461-32D363AE0B0BQ34151104-A712B836-F5FF-4C9B-A4A5-0AAB63CE7DE8Q34391616-8AA49EF3-4111-49AC-BBDE-5B0BD3638818Q35071802-A2AFFEA8-DC30-490D-B601-6277A43A96E1Q35170354-59F07160-6982-4705-A76C-C6E14446651FQ35662625-7F5F0641-149F-40C8-A2FB-CB51A8AEDB6FQ36260369-C3B8DD28-1E3F-403C-8993-B6845C20BD75Q37075669-12A73D30-9110-449E-895E-0BA37469EA18Q38286205-FE9511A8-CE29-4B21-BE26-3A75B4FF6C30Q39711144-59E5914D-23F9-46B2-9B31-D4F962141E10Q39743749-D91B3C82-43E7-45BF-AEF7-E5951BCCD872Q39847007-E86E03A6-7803-4ED3-834E-E98FDB1DBEDBQ42113713-E13E3B15-A50C-4488-95DE-6F578D60A761Q42544286-8C194169-6B21-48D9-9E71-AD2A1C755C01Q45275684-6F9A7650-A0D4-447B-BDD6-001602B3A281Q47110262-B47A5A7F-35A5-4CEA-99CC-0F26931C843DQ47288431-D4A430EC-E1D1-4A28-9CE0-86ED2C8B459EQ47873490-4BB3BEF1-F3B3-4644-A7D3-E469EB3406C0Q47911653-41D0646D-3B6E-4D23-AF20-DB0CFB05B79CQ47937629-D8378EA7-7C93-4A20-89FD-C3D4553439EFQ48180975-39327307-D490-4914-8A55-83C7D61DAE9CQ48912595-3EBF3CDF-F0BF-4431-BC3A-1FEDB3C13E8EQ51120189-2812E68A-2370-482F-91CF-A3FB08BDCFBEQ52316042-EC9DFB45-FEF3-4ECA-92C0-D9313C4E708BQ53396323-5C3ABE3A-5FB9-4254-B0A7-4D87464F7F2AQ55250288-62DC337C-1FA5-4E18-A627-889064953FBFQ55276177-C2D03C75-1538-4310-ADCD-CBE549D52CD4Q57183034-FFDF18CA-E059-4043-92A4-14F0D1DE3FD9Q57490780-1D22E687-616D-476B-B3B9-42457934373DQ58722127-0D1029E1-DD90-44CA-B5F3-E615368957DFQ58752961-A26BB1C4-42DF-4980-BF9D-4FFD919B99B6Q58794404-EF7BDFC0-AEAD-401E-A4A9-F8E9D930A283
P2860
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
@en
type
label
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
@en
prefLabel
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
@en
P2860
P1476
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
@en
P2093
Jungsook Cho
Shambhunath Bose
P2860
P2888
P304
P356
10.1007/S12272-013-0161-Z
P577
2013-06-15T00:00:00Z
P6179
1028011234